These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16180015)

  • 1. Expression of VDR and CYP24A1 mRNA in human tumors.
    Anderson MG; Nakane M; Ruan X; Kroeger PE; Wu-Wong JR
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):234-40. PubMed ID: 16180015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
    Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
    Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X; Feldman D
    Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.
    Lechner D; Kállay E; Cross HS
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):55-64. PubMed ID: 17029768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
    Matsunawa M; Amano Y; Endo K; Uno S; Sakaki T; Yamada S; Makishima M
    Toxicol Sci; 2009 May; 109(1):50-8. PubMed ID: 19244278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.
    Horvath E; Lakatos P; Balla B; Kósa JP; Tóbiás B; Jozilan H; Borka K; Horváth HC; Kovalszky I; Szalay F
    Anticancer Res; 2012 Nov; 32(11):4791-6. PubMed ID: 23155244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
    Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
    Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
    Reinhardt TA; Horst RL
    Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
    DeSmet ML; Fleet JC
    J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
    de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
    Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.